Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    Open Studies | "Organ Transplantation"
Show Display Options
Rank Status Study
21 Recruiting Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
Condition: Gram Negative Infection
Intervention:
22 Recruiting Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate gel 0.015%
23 Recruiting HIV-to-HIV Transplant at MGH
Conditions: HIV;   Awaiting Organ Transplant
Intervention:
24 Recruiting Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
Conditions: Validation Study of Molecular Diagnostic System;   Development of Reporting System for Molecular Diagnosis;   Incorporate Molecular Diagnosis Into Diagnostic Standards
Intervention:
25 Recruiting The ONE Study UK Treg Trial
Condition: End-stage Renal Failure
Intervention: Biological: Autologous regulatory T Cell Product
26 Recruiting The ONE Study M Reg Trial
Condition: Renal Failure, End Stage
Intervention: Biological: Donor M reg (Mreg_UKR)
27 Recruiting Transplantoux Health Evaluation Study
Condition: Quality of Life
Interventions: Other: Home-based indiviualized exercise training program;   Other: Supervised group training sessions;   Other: Climb of the Mont Ventoux
28 Recruiting Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
Conditions: Hepatitis B;   Cirrhosis;   Awaiting Organ Transplant
Intervention: Biological: HBV vaccine
29 Recruiting Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
Conditions: Influenza, Human;   Transplantation Infection
Interventions: Biological: influenza trivalent inactive vaccine;   Biological: influenza trivalent inactive vaccine high dose
30 Recruiting Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL
Conditions: Invasive Fungal Infection;   Hematological Malignancy;   Receipt of Solid Organ Transplant
Intervention: Other: Fungitell Assay in BAL
31 Recruiting Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft Versus Host Disease;   Chronic GVHD;   Complications of Organ Transplant Stem Cells
Interventions: Other: Treg-enriched infusion;   Drug: Interleukin-2
32 Recruiting A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Conditions: Kidney Transplantation;   Liver Transplantation;   Heart Transplantation
Interventions: Drug: Prograf®;   Drug: Advagraf
33 Recruiting Cell-mediated Immunity for Prevention of CMV Disease
Condition: Cytomegalovirus Infections
Intervention: Other: T-Track® CMV assay
34 Not yet recruiting Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive Cluster of Differentiation(CD) 20-Positive Post-Transplant Lymphoproliferative Disorder
Conditions: Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder;   Monomorphic Post-Transplant Lymphoproliferative Disorder;   Polymorphic Post-Transplant Lymphoproliferative Disorder
Interventions: Biological: Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes;   Other: Laboratory Biomarker Analysis;   Biological: Rituximab
35 Recruiting Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy
Condition: Posttransplant Lymphoproliferative Disorder
Interventions: Drug: Rituximab sc;   Drug: Rituximab sc consolidation;   Drug: Rituximab sc combined with CHOP chemotherapy;   Drug: Rituximab sc combined with alternating chemotherapy with CHOP and DHAOx
36 Recruiting Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation
Condition: Liver Transplantation
Intervention: Drug: MultiStem
37 Not yet recruiting Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Conditions: Extensive Photodamage;   Actinic Keratosis;   History of Numerous Skin Cancers
Interventions: Device: Ultrapulse Carbon Dioxide Laser;   Device: Cellutome epidermal harvesting system
38 Recruiting New Generation IGRA in Immunocompromised Individuals
Conditions: Monitoring, Immunologic;   Active Tuberculosis;   Tuberculosis in Solid Organ Transplant Recipients;   Tuberculosis in Marrow Transplant Recipients;   Tuberculosis in Rheumatoid Arthritis;   Tuberculosis in Chronic Renal Failure;   Tuberculosis in HIV-infected Individuals
Intervention:
39 Recruiting Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients
Condition: Cytomegalovirus Viraemia
Intervention: Drug: Valganciclovir or Ganciclovir
40 Recruiting University of Minnesota Transplant Registry
Conditions: Transplant Recipient;   Transplant Donation
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.